[go: up one dir, main page]

AU2002347359A1 - Quinoline derivatives - Google Patents

Quinoline derivatives

Info

Publication number
AU2002347359A1
AU2002347359A1 AU2002347359A AU2002347359A AU2002347359A1 AU 2002347359 A1 AU2002347359 A1 AU 2002347359A1 AU 2002347359 A AU2002347359 A AU 2002347359A AU 2002347359 A AU2002347359 A AU 2002347359A AU 2002347359 A1 AU2002347359 A1 AU 2002347359A1
Authority
AU
Australia
Prior art keywords
quinoline derivatives
quinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002347359A
Inventor
Laurent Francois Andre Hennequin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002347359A1 publication Critical patent/AU2002347359A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002347359A 2001-12-05 2002-12-05 Quinoline derivatives Abandoned AU2002347359A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01403125 2001-12-05
EP01403125.6 2001-12-05
PCT/GB2002/005535 WO2003047584A1 (en) 2001-12-05 2002-12-05 Quinoline derivatives

Publications (1)

Publication Number Publication Date
AU2002347359A1 true AU2002347359A1 (en) 2003-06-17

Family

ID=8183000

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002347359A Abandoned AU2002347359A1 (en) 2001-12-05 2002-12-05 Quinoline derivatives

Country Status (2)

Country Link
AU (1) AU2002347359A1 (en)
WO (1) WO2003047584A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292137A1 (en) 2000-10-13 2002-04-22 Astrazeneca Ab Quinazoline derivatives
US6849625B2 (en) 2000-10-13 2005-02-01 Astrazeneca Ab Quinazoline derivatives with anti-tumour activity
JP4326328B2 (en) 2001-07-16 2009-09-02 アストラゼネカ アクチボラグ Quinoline derivatives and their use as tyrosine kinase inhibitors
US7576074B2 (en) 2002-07-15 2009-08-18 Rice Kenneth D Receptor-type kinase modulators and methods of use
GB0225579D0 (en) * 2002-11-02 2002-12-11 Astrazeneca Ab Chemical compounds
WO2005030140A2 (en) 2003-09-26 2005-04-07 Exelixis, Inc. C-met modulators and methods of use
CL2008002384A1 (en) 2007-08-15 2009-07-17 Glaxo Group Ltd Compounds derived from quinolinyloxypiperidine and pyrrolidine, pharmaceutical composition, pharmaceutical combination, useful for the treatment of inflammatory and / or allergic diseases of the respiratory tract.
DK2387563T4 (en) 2009-01-16 2022-07-18 Exelixis Inc MALATE SALT OF N-(4-{ [ 6, 7-BIS(METHYLOXY)QUINOLIN-4-YL]OXY}PHENYL-N'-(4-FLUORPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE, AND CRYSTALLINE FORMS THEREOF FOR THE TREATMENT OF CANCER
UA108618C2 (en) 2009-08-07 2015-05-25 APPLICATION OF C-MET-MODULATORS IN COMBINATION WITH THEMOSOLOMID AND / OR RADIATION THERAPY FOR CANCER TREATMENT
EP3194572B1 (en) 2014-07-30 2023-10-25 Yeda Research and Development Co. Ltd. Media for culturing pluripotent stem cells
JP6224872B1 (en) * 2014-10-20 2017-11-01 ユナイテッド セラピューティクス コーポレイション Synthesis of intermediates to produce prostacyclin derivatives.
EP3359526A4 (en) 2015-10-05 2019-04-03 The Trustees of Columbia University in the City of New York ACTIVATORS OF AUTOPHAGIC FLOW AND PHOSPHOLIPASE D AND CLAIRANCE OF PROTEIN AGGREGATES COMPRISING TAU AND TREATMENT OF PROTEINEOPATHIES
EP3914698B1 (en) 2019-01-23 2024-12-11 Yeda Research and Development Co. Ltd Culture media for pluripotent stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA73073C2 (en) * 1997-04-03 2005-06-15 Уайт Холдінгз Корпорейшн Substituted 3-cyan chinolines
JP4548642B2 (en) * 1998-09-29 2010-09-22 アメリカン・サイアナミド・カンパニー Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors
GB9910577D0 (en) * 1999-05-08 1999-07-07 Zeneca Ltd Chemical compounds
JP4326328B2 (en) * 2001-07-16 2009-09-02 アストラゼネカ アクチボラグ Quinoline derivatives and their use as tyrosine kinase inhibitors

Also Published As

Publication number Publication date
WO2003047584A1 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2002349676A1 (en) 4-oxoquinoline derivatives
IL159288A0 (en) Tetrahydroquinoline derivatives
AU2002352142A1 (en) Pyrazolopyridine derivatives
AUPR975601A0 (en) Quinazolinone derivatives
AU2002347336A1 (en) Quinoline derivatives
AU2002331707A1 (en) Tetrahydroquinoline derivatives as antithrombotic agents
AU2002347359A1 (en) Quinoline derivatives
GB0104422D0 (en) Quinoline derivative
AU2003274551A1 (en) Quinoline derivatives
AU2002363600A1 (en) Novel phenyl-propargylether derivatives
AU2003252333A1 (en) Novel tetrahydroquinoline derivatives
AU2002365664A1 (en) Quinoline derivatives as antitumour agents
AU2002358715A1 (en) Tetrahydrobenzfluorene derivatives
AU2002233664A1 (en) Naphthyridine derivative
AU2002255269B8 (en) 2-Iminopyrrolidine derivatives
AU2002305184A1 (en) Cycloalkenylsulfonamide derivatives
AU2002350425A1 (en) 6-phenyldihydropyrrolopyrimidinedione derivatives
AU2002354530A1 (en) 4-phenylpyran-2-one derivatives
AU2002325368A1 (en) Benzoylcyclohexenone derivatives
AU2002253080A1 (en) Biurethane derivatives
HK1062431A (en) A-amino-n-hydroxy-acetamide derivatives
AU2002225034A1 (en) Rustmicin derivatives
AU2002302578A1 (en) Amido-diphenyl derivatives
AU2002230196A1 (en) Dicarba-closo-dodecarborane derivatives
AU2002249205A1 (en) Bis-triazinylaminobenzoxazole derivatives

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase